|
| 38043226 | Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016-17. | Drug Alcohol Depend | 2024 |
| 36376632 | Outcomes of Patients with Opioid-Related Diagnoses in Acute Coronary Syndrome: a National Inpatient Sample-Based Analysis. | J Gen Intern Med | 2023 |
| 37716904 | URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEW. | J Emerg Med | 2023 |
| 37713393 | Computational phenotypes for patients with opioid-related disorders presenting to the emergency department. | PLoS One | 2023 |
| 37524371 | Perspectives on contingency management for alcohol use and alcohol-associated conditions among people in care with HIV. | Alcohol Clin Exp Res (Hoboken) | 2023 |
| 37751206 | Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy. | JAMA Netw Open | 2023 |
| 37788621 | Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States. | J Addict Med | 2023 |
| 37788607 | Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys. | J Addict Med | 2023 |
| 37579115 | Availability of Specific Programs and Medications for Addiction Treatment to Vulnerable Populations: Results from the Addiction Treatment Locator, Assessment, and Standards (ATLAS) Survey. | J Addict Med | 2023 |
| 37017967 | Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder. | JAMA Netw Open | 2023 |
| 37149149 | Perspectives on and experiences of emergency department-initiated buprenorphine among clinical pharmacists: A multi-site qualitative study. | J Subst Use Addict Treat | 2023 |
| 37280036 | Efficacy of alcohol reduction interventions among people with HIV as evaluated by self-report and a phosphatidylethanol (PEth) outcome: protocol for a systematic review and individual participant data meta-analysis. | BMJ Open | 2023 |
| 37178101 | National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use Disorder. | Ann Emerg Med | 2023 |
| 37140493 | Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled Trial. | Ann Emerg Med | 2023 |
| 37230168 | Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trial. | Contemp Clin Trials | 2023 |
| 37163263 | Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs. | JAMA Netw Open | 2023 |
| 36995717 | Incidence of Precipitated Withdrawal During a Multisite Emergency Department-Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. | JAMA Netw Open | 2023 |
| 36738634 | Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis. | Drug Alcohol Depend | 2023 |
| 36170184 | Missed Opportunities for HIV and Hepatitis C Screening Among Emergency Department Patients With Untreated Opioid Use Disorder. | J Addict Med | 2023 |
| 34049315 | SOAPs and SUDs: Patients With Substance Use Disorders and What Clinicians Should Know About the Cures Act. | J Addict Med | 2022 |
| 35768956 | Association of topiramate prescribed for any indication with reduced alcohol consumption in electronic health record data. | Addiction | 2022 |
| 35430700 | Bridging the Gap: Dual Fellowship Training in Addiction Medicine and Digestive Diseases. | Dig Dis Sci | 2022 |
| 35657646 | Strategic planning for addiction programs within academic medical centers: Examples from the Yale Program in Addiction Medicine. | Subst Abus | 2022 |
| 36515952 | Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment. | JAMA Netw Open | 2022 |
| 36251291 | Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV Clinics: A Randomized Clinical Trial. | JAMA Netw Open | 2022 |
| 36166675 | Buprenorphine Initiation in the Era of High-potency Synthetic Opioids: A Call for Community-based Participatory Research to Help Learning Health Systems Provide Precision Medicine for Opioid Use Disorder. | J Addict Med | 2022 |
| 36123420 | Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies. | Mol Psychiatry | 2022 |
| 36121359 | Physician response to COVID-19-driven telehealth flexibility for opioid use disorder. | Am J Manag Care | 2022 |
| 35156912 | Identifying opioid-related electronic health record phenotypes for emergency care research and surveillance: An expert consensus driven concept mapping process. | Subst Abus | 2022 |
| 35067362 | Association of Poor Mental-Health Days With COVID-19 Infection Rates in the U.S. | Am J Prev Med | 2022 |
| 35001249 | The Relationship Between Drinking Behavior and Conversational Processes During a Brief Alcohol Reduction Intervention for People with HIV. | AIDS Behav | 2022 |
| 35032081 | Low- and very low-dose buprenorphine induction: new(ish) uses for an old(ish) medication? | Addiction | 2022 |
| 35025898 | Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics. | PLoS One | 2022 |
| 35341613 | Patients' perspectives of medications for addiction treatment in HIV clinics: A qualitative study. | J Subst Abuse Treat | 2022 |
| 35020698 | Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. | J Addict Med | 2022 |
| 35293064 | The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study. | Addiction | 2022 |
| 35076700 | Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder. | JAMA Netw Open | 2022 |
| 34495424 | Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV. | AIDS Behav | 2022 |
| 34542779 | Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV. | AIDS Behav | 2022 |
| 34130128 | Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. | J Subst Abuse Treat | 2022 |
| 34001776 | A Case of Kratom Use: Implications for Managing Addiction and Addressing Comorbidity in Overdose Survivors, and for the Education of Clinicians Who Are Not Addiction Specialists. | J Addict Med | 2022 |
| 32482955 | Recommended Use of Terminology in Addiction Medicine. | J Addict Med | 2021 |
| 33737199 | The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation. | Contemp Clin Trials | 2021 |
| 33675619 | Readiness to Provide Medications for Addiction Treatment in HIV Clinics: A Multisite Mixed-Methods Formative Evaluation. | J Acquir Immune Defic Syndr | 2021 |
| 33509278 | Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study. | Trials | 2021 |
| 33667784 | Psychiatric comorbidity and order of condition onset among patients seeking treatment for chronic pain and opioid use disorder. | Drug Alcohol Depend | 2021 |
| 33837975 | Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta-analysis. | Alcohol Clin Exp Res | 2021 |
| 33750454 | Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study. | Addict Sci Clin Pract | 2021 |
| 33583610 | The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail. | J Subst Abuse Treat | 2021 |
| 34877567 | Emergency department-initiated buprenorphine protocols: A national evaluation. | J Am Coll Emerg Physicians Open | 2021 |